Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FLAT: Fludarabine, Cytarabine and Topotecan in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

NCT00488709 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT00488709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00488709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FLAT: Fludarabine, Cytarabine and Topotecan in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Lead sponsor
PETHEMA Foundation
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2003
Completion date
April 30, 2007
Enrollment
47 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia